Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Wednesday’s trading has closed, but REGN is being traded in the after-hours session. After-Hours quote »
413.04
Delayed Data
As of 3:59pm ET
 +0.54 / +0.13%
Today’s Change
269.50
Today|||52-Week Range
437.64
+0.68%
Year-to-Date

Today’s Trading

Previous close412.51
Today’s open409.17
Day’s range408.21 - 415.88
Volume590,941
Average volume (3 months)831,902
Market cap$42.3B
Dividend yield--
Data as of 3:59pm ET, 03/04/2015

Growth & Valuation

Earnings growth (last year)-19.42%
Earnings growth (this year)+4.30%
Earnings growth (next 5 years)+15.72%
Revenue growth (last year)+33.96%
P/E ratio134.5
Price/Sales14.64
Price/Book16.62

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+0.32+0.30%
ISISIsis Pharmaceuticals...+1.50+2.18%
QQuintiles Transnatio...-0.61-0.93%
ICLRICON PLC-0.34-0.50%
Data as of 4:03pm ET, 03/04/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$2.70
Annual revenue (last year)$2.8B
Annual profit (last year)$348.1M
Net profit margin12.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account